Intelligent Medical Objects Announces the Acquisition of Melax Technologies

Intelligent Medical Objects Announces the Acquisition of Melax Technologies

Intelligent Medical Objects (IMO) announced that it has acquired Melax Technologies for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 110th eHealth transaction of the year, and the 18th in the analytics specialty. Melax Technologies is a healthcare data analytics and business intelligence company focused on Natural Language Processing that provides healthcare organizations with actionable insights into clinical and financial performance. The company is trusted by more than 650 healthcare organizations. Founded in 1994, IMO is a healthcare data enablement company that provides clinical terminology management and data quality... Read More »
TUSK Partners Advises Grinz Orthodontics in Sale to Smile Doctors

TUSK Partners Advises Grinz Orthodontics in Sale to Smile Doctors

Smile Doctors, a portfolio company of Linden Capital Partners and Thomas H. Lee Partners, has acquired Grinz Orthodontics for an undisclosed price. The dental-focused M&A advisor TUSK Partners represented Grinz Orthodontics in the sale. Founded in 2006, Grinz Orthodontics provides orthodontic care to communities throughout North Carolina and Arizona. Under the leadership of Dr. Richard Ziehmer, Grinz Orthodontics is committed to providing premier dental care to its communities with a patient-centered approach. Smile Doctors is an orthodontic dental support organization with more than 370 locations in 27 states. According to data captured in the LevinPro HC database, this acquisition... Read More »
Adare Pharmaceuticals Sold to Two Private Equity Firms

Adare Pharmaceuticals Sold to Two Private Equity Firms

Two private equity firms, Thomas H. Lee Partners and Frazier Healthcare Partners, are teaming up to acquire a leading specialty contract development and manufacturing organization (CDMO). The firms are buying Adare Pharmaceuticals. a global provider of advanced pharmaceutical technologies, development and manufacturing. The company utilizes its differentiated pharmaceutical technology and microbiome scientific platforms to develop novel, improved medicines and therapies for the global market. Adare has developed and manufactured more than 40 products sold by partners in more than 100 countries globally including Lacteol, Zoolac, Viactiv, and a number of branded and complex generic... Read More »
Autism Therapy Tops PE’s List in December

Autism Therapy Tops PE’s List in December

A good number of behavioral health care deals have been announced in Decmeber 2019 and the majority of those target companies providing therapy services to individuals with autism and intellectual and developmental disabilities (I/DD). Seven deals in the Behavioral Health Care sector are on the books mid-way through the month and five offer some form of applied behavior analysis (ABA) therapy or services. The two remaining deals target companies specializing in residential substance abuse treatment and inpatient addiction and eating disorders for teens. Thomas H. Lee Partners announced the only deal to disclose a price. The firm paid $415 million (16.6x EBITDA) for Centria Healthcare, a... Read More »
Irving Place Capital Exits Universal Hospital Services

Irving Place Capital Exits Universal Hospital Services

Irving Place Capital Management scored big in August — $1.74 billion big. The private equity firm sold Universal Hospital Services, a medical equipment management company, to Federal Street Acquisition Corp. (NASDAQ: FSAC), a special purpose acquisition company sponsored by an affiliate of Thomas H. Lee Partners. Universal Hospital’s diverse customer base includes over 4,000 acute care hospitals, 4,000 alternate site providers, and over 150 major medical equipment manufacturers. Under the terms of the agreement, Federal Street and Universal Hospital will combine under a new holding company to be named Agiliti, Inc., which intends to apply to have its common stock and warrants... Read More »